Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus

[1]  J. Dalmau,et al.  Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies. , 2015, JAMA neurology.

[2]  M. Dalakas,et al.  GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders , 2015, Journal of Neuroimmunology.

[3]  J. Dalmau,et al.  Antibodies to Inhibitory Synaptic Proteins in Neurological Syndromes Associated with Glutamic Acid Decarboxylase Autoimmunity , 2015, PloS one.

[4]  J. Jankovic,et al.  Stiff-person syndrome: insights into a complex autoimmune disorder , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  J. Dalmau,et al.  Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. , 2014, JAMA neurology.

[6]  J. Dalmau,et al.  Autoimmune encephalitis as differential diagnosis of infectious encephalitis. , 2014, Current opinion in neurology.

[7]  W. Mason,et al.  Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies , 2014, The Lancet Neurology.

[8]  F. Durif,et al.  Intravenous Immunoglobulin and Rituximab for Cerebellar Ataxia with Glutamic Acid Decarboxylase Autoantibodies , 2013, The Cerebellum.

[9]  M. Dalakas,et al.  Immunology of stiff person syndrome and other GAD-associated neurological disorders , 2013, Expert review of clinical immunology.

[10]  L. Santoro,et al.  Anti-GAD antibody ocular flutter: expanding the spectrum of autoimmune ocular motor disorders , 2013, Journal of Neurology.

[11]  M. Rowley,et al.  Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies. , 2011, Journal of autoimmunity.

[12]  A. García-Zarza,et al.  Cerebellar ataxia associated with neuroendocrine thymic carcinoma and GAD antibodies , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[13]  L. Ramió-Torrentá,et al.  Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. , 2008, Brain : a journal of neurology.

[14]  S. Sorbi,et al.  Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies , 2008, Journal of Neuroimmunology.

[15]  H. Gil,et al.  Syndrome de la personne raide associé à un thymome : efficacité de la thymectomie , 2007 .

[16]  T. Lynch,et al.  GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma , 2007, Movement disorders : official journal of the Movement Disorder Society.

[17]  M. Seeck,et al.  Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  E. Benarroch,et al.  Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. , 2006, Mayo Clinic proceedings.

[19]  B. Giometto,et al.  Antigenic differences between neurological and diabetic patients with anti‐glutamic acid decarboxylase antibodies , 2005, European journal of neurology.

[20]  M. Rewers,et al.  Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. , 2005, Diabetes care.

[21]  O. Kordonouri,et al.  Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty , 2005, Archives of Disease in Childhood.

[22]  M. Dalakas,et al.  Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. , 2004, Archives of neurology.

[23]  D. Schiff,et al.  Anti-GAD Antibody Positive Stiff-Limb Syndrome in Multiple Myeloma , 2003, Journal of Neuro-Oncology.

[24]  A. Kitabchi,et al.  Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. , 2003, Diabetes care.

[25]  B. Giometto,et al.  Glutamic acid decarboxylase autoantibodies and neurological disorders , 2002, Neurological Sciences.

[26]  O. Kordonouri,et al.  Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. , 2002, Diabetes care.

[27]  M. Dalakas,et al.  High-dose intravenous immune globulin for stiff-person syndrome. , 2001, The New England journal of medicine.

[28]  D. Jacobowitz,et al.  Stiff person syndrome: Advances in pathogenesis and therapeutic interventions , 2001, Neurology.

[29]  N. Morgenthaler,et al.  Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases , 2001, Journal of neurology, neurosurgery, and psychiatry.

[30]  A. Vighetto,et al.  Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. , 2001, Archives of neurology.

[31]  M. Knip,et al.  Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy , 2000, Neurology.

[32]  H. Mitoma,et al.  Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase , 2000, Journal of the Neurological Sciences.

[33]  C. Marsden,et al.  Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity , 1998, Journal of neurology, neurosurgery, and psychiatry.

[34]  H. Meinck,et al.  Inhibition of γ‐aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff‐man syndrome , 1998 .

[35]  J. Stengård,et al.  Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.

[36]  L. Velloso,et al.  GAD Autoantibodies in IDDM, Stiff-Man Syndrome, and Autoimmune Polyendocrine Syndrome Type I Recognize Different Epitopes , 1994, Diabetes.

[37]  P. Camilli,et al.  The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer , 1993, The Journal of experimental medicine.

[38]  P. De Camilli,et al.  Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. , 1988, The New England journal of medicine.

[39]  H. Mitoma,et al.  Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia. , 2016, Internal medicine.